dalteparin has been researched along with Aortitis Syndrome in 2 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jacquemyn, Y | 1 |
| Vercauteren, M | 1 |
| Darmochwał-Kolarz, D | 1 |
| Chara, A | 1 |
| Korzeniewski, M | 1 |
| Leszczyńska-Gorzelak, B | 1 |
| Oleszczuk, J | 1 |
2 other studies available for dalteparin and Aortitis Syndrome
| Article | Year |
|---|---|
Pregnancy and Takayasu's arteritis of the pulmonary artery.
Topics: Adult; Anticoagulants; Female; Humans; Methylprednisolone; Nadroparin; Pregnancy; Pregnancy Complica | 2005 |
[Takayasu's arteritis in pregnancy--a case report].
Topics: Antihypertensive Agents; Cesarean Section; Enoxaparin; Female; Humans; Infant, Newborn; Male; Pregna | 2014 |